Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Clinical Study Details
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
-
Autoimmune Disorder -
Inflammatory Bowel Disease (IBD) -
Ulcerative Colitis
- Results
-
Download -
Study results
LPS GA44839 Final Results November 2025 English
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 Polish
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 Greek
(PDF, 1.3 MB)
LPS GA44839 Final Results November 2025 Serbian
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 Czech
(PDF, 0.9 MB)
LPS GA44839 Final Results November 2025 French
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 Portuguese
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 Italian
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 Korean
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 Mexico Spanish
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 USA Spanish
(PDF, 0.8 MB)
LPS GA44839 Final Results November 2025 Taiwan Chinese
(PDF, 0.9 MB)
LPS GA44839 Final Results November 2025 China Chinese
(PDF, 1.0 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com